首页> 外文会议>International conference on parallel problem solving from nature >Robust Evolutionary Bi-objective Optimization for Prostate Cancer Treatment with High-Dose-Rate Brachytherapy
【24h】

Robust Evolutionary Bi-objective Optimization for Prostate Cancer Treatment with High-Dose-Rate Brachytherapy

机译:高剂量率近距离放射治疗前列腺癌的鲁棒进化双目标优化

获取原文

摘要

We address the real-world problem of automating the design of high-quality prostate cancer treatment plans in case of high-dose-rate brachytherapy, a form of internal radiotherapy. For this, recently a bi-objective real-valued problem formulation was introduced. With a GPU parallelization of the Multi-Objective Real-Valued Gene-pool Optimal Mixing Evolutionary Algorithm (MO-RV-GOMEA), good treatment plans were found in clinically acceptable running times. However, optimizing a treatment plan and delivering it to the patient in practice is a two-stage decision process and involves a number of uncertainties. Firstly, there is uncertainty in the identified organ boundaries due to the limited resolution of the medical images. Secondly, the treatment involves placing catheters inside the patient, which always end up (slightly) different from what was optimized. An important factor is therefore the robustness of the final treatment plan to these uncertainties. In this work, we show how we can extend the evolutionary optimization approach to find robust plans using multiple scenarios without linearly increasing the amount of required computation effort, as well as how to deal with these uncertainties efficiently when taking into account the sequential decision-making moments. The performance is tested on three real-world patient cases. We find that MO-RV-GOMEA is equally well capable of solving the more complex robust problem formulation, resulting in a more realistic reflection of the treatment plan qualities.
机译:在高剂量率近距离放射疗法(一种内部放射疗法)的情况下,我们解决了自动化设计高质量前列腺癌治疗计划的现实问题。为此,最近引入了一种双目标实值问题公式。通过多目标实值基因池最优混合进化算法(MO-RV-GOMEA)的GPU并行化,在临床可接受的运行时间中找到了良好的治疗计划。然而,优化治疗计划并在实践中将其交付给患者是一个分为两个阶段的决策过程,并且存在许多不确定性。首先,由于医学图像的分辨率有限,在识别出的器官边界中存在不确定性。其次,治疗包括将导管置入患者体内,导管最终(略微)与优化后的导管不同。因此,重要的因素是最终治疗计划对这些不确定性的鲁棒性。在这项工作中,我们展示了如何扩展进化优化方法以使用多个场景找到鲁棒的计划,而不会线性增加所需的计算工作量,以及如何在考虑顺序决策时有效地处理这些不确定性片刻。该性能已在三个现实世界的患者案例中进行了测试。我们发现,MO-RV-GOMEA同样能够解决更复杂的鲁棒性问题,从而更加真实地反映了治疗计划的质量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号